Gilead's $2,340 price for coronavirus drug draws criticism



The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries.

Gilead Sciences announced the price Monday for remdesivir, and said the price would be $3,120 for patients with private insurance. The amount that patients pay out of pocket depends on insurance, income and other factors.

“They believe that we had to really deviate from the normal circumstances” and price the drug to ensure wide access rather than based solely on value to patients, he said.

   


However, the price was swiftly criticized; a consumer group called it “an outrage” because of the amount taxpayers invested toward the drug's development.

Gilead's $2,340 price for coronavirus drug draws criticism Gilead's $2,340 price for coronavirus drug draws criticism Reviewed by Anson Moore on June 29, 2020 Rating: 5

No comments:

Powered by Blogger.